BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38775405)

  • 1. A clinical nomogram for predicting occult lymph node metastasis in patients with non-small cell lung cancer≤2 cm.
    Ai J; Gao H; Shi G; Lan Y; Hu S; Wang Z; Liu L; Wei Y
    Interdiscip Cardiovasc Thorac Surg; 2024 May; ():. PubMed ID: 38775405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
    Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 4. A nomogram for predicting the risk of lymph node metastasis in T1-2 non-small-cell lung cancer based on PET/CT and clinical characteristics.
    Lv X; Wu Z; Cao J; Hu Y; Liu K; Dai X; Yuan X; Wang Y; Zhao K; Lv W; Hu J
    Transl Lung Cancer Res; 2021 Jan; 10(1):430-438. PubMed ID: 33569324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
    He C; Ni M; Liu J; Teng X; Ke L; Matsuura Y; Okuda K; Sakairi Y; Cheng J; Yu L; Lv W; Hu J
    Transl Lung Cancer Res; 2024 Mar; 13(3):573-586. PubMed ID: 38601448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
    Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
    Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Qiao J; Zhang X; Du M; Wang P; Xin J
    Front Oncol; 2022; 12():974934. PubMed ID: 36249026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics Analysis and Nomogram Risk Prediction of Occult Lymph Node Metastasis in Non-Predominant Micropapillary Component of Lung Adenocarcinoma Measuring ≤ 3 cm.
    Wang K; Xue M; Qiu J; Liu L; Wang Y; Li R; Qu C; Yue W; Tian H
    Front Oncol; 2022; 12():945997. PubMed ID: 35912197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting occult lymph node metastasis by nomogram in patients with lung adenocarcinoma ≤2 cm.
    Wang Z; Wu Y; Wang L; Gong L; Han C; Liang N; Li S
    Future Oncol; 2021 Jun; 17(16):2005-2013. PubMed ID: 33784826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel nomogram to predict lymph node metastasis in cT1 non-small-cell lung cancer based on PET/CT and peripheral blood cell parameters.
    Wei B; Jin X; Lu G; Zhao T; Xue H; Zhang Y
    BMC Pulm Med; 2023 Jan; 23(1):44. PubMed ID: 36717907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.
    Chen M; Yang Y; He C; Chen L; Cheng J
    J Xray Sci Technol; 2022; 30(3):599-612. PubMed ID: 35311733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
    Xue M; Liu J; Li Z; Lu M; Zhang H; Liu W; Tian H
    BMC Cancer; 2024 Jan; 24(1):139. PubMed ID: 38287300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A nomogram for predicting lymph node metastasis in early gastric cancer].
    Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
    [No Abstract]   [Full Text] [Related]  

  • 14. An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer.
    Wu Y; Han C; Wang Z; Gong L; Liu J; Chong Y; Liu X; Liang N; Li S
    Front Oncol; 2020; 10():1322. PubMed ID: 32850420
    [No Abstract]   [Full Text] [Related]  

  • 15. Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer.
    Jiang L; Jiang S; Lin Y; Yang H; Xie Z; Lin Y; Long H
    Medicine (Baltimore); 2015 Nov; 94(46):e2054. PubMed ID: 26579815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics-clinical nomogram for preoperative lymph node metastasis prediction in esophageal carcinoma.
    Geng X; Zhang Y; Li Y; Cai Y; Liu J; Geng T; Meng X; Hao F
    Br J Radiol; 2024 Feb; 97(1155):652-659. PubMed ID: 38268475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
    Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
    Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study.
    Chen QL; Li MM; Xue T; Peng H; Shi J; Li YY; Duan SF; Feng F
    Clin Radiol; 2023 May; 78(5):e359-e367. PubMed ID: 36858926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.